rs2502815

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005122.5(NR1I3):​c.239-99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 1,273,808 control chromosomes in the GnomAD database, including 47,121 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6300 hom., cov: 32)
Exomes 𝑓: 0.26 ( 40821 hom. )

Consequence

NR1I3
NM_005122.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.635

Publications

25 publications found
Variant links:
Genes affected
NR1I3 (HGNC:7969): (nuclear receptor subfamily 1 group I member 3) This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020]
NR1I3 Gene-Disease associations (from GenCC):
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.412 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR1I3NM_005122.5 linkc.239-99C>T intron_variant Intron 3 of 8 ENST00000367983.9 NP_005113.1 Q14994-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR1I3ENST00000367983.9 linkc.239-99C>T intron_variant Intron 3 of 8 1 NM_005122.5 ENSP00000356962.5 Q14994-2

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
42926
AN:
151912
Hom.:
6292
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.312
Gnomad AMI
AF:
0.253
Gnomad AMR
AF:
0.323
Gnomad ASJ
AF:
0.260
Gnomad EAS
AF:
0.427
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.289
GnomAD4 exome
AF:
0.265
AC:
297223
AN:
1121778
Hom.:
40821
AF XY:
0.264
AC XY:
148037
AN XY:
561730
show subpopulations
African (AFR)
AF:
0.331
AC:
8836
AN:
26732
American (AMR)
AF:
0.380
AC:
14067
AN:
36996
Ashkenazi Jewish (ASJ)
AF:
0.254
AC:
5302
AN:
20912
East Asian (EAS)
AF:
0.434
AC:
16250
AN:
37422
South Asian (SAS)
AF:
0.274
AC:
19672
AN:
71706
European-Finnish (FIN)
AF:
0.288
AC:
10750
AN:
37388
Middle Eastern (MID)
AF:
0.274
AC:
920
AN:
3360
European-Non Finnish (NFE)
AF:
0.248
AC:
207740
AN:
838636
Other (OTH)
AF:
0.281
AC:
13686
AN:
48626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
10466
20931
31397
41862
52328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6920
13840
20760
27680
34600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
42969
AN:
152030
Hom.:
6300
Cov.:
32
AF XY:
0.286
AC XY:
21220
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.312
AC:
12935
AN:
41466
American (AMR)
AF:
0.323
AC:
4937
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.260
AC:
904
AN:
3472
East Asian (EAS)
AF:
0.427
AC:
2205
AN:
5164
South Asian (SAS)
AF:
0.283
AC:
1361
AN:
4816
European-Finnish (FIN)
AF:
0.291
AC:
3073
AN:
10556
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.244
AC:
16607
AN:
67958
Other (OTH)
AF:
0.296
AC:
626
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1529
3058
4588
6117
7646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.267
Hom.:
1652
Bravo
AF:
0.296
Asia WGS
AF:
0.352
AC:
1221
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
12
DANN
Benign
0.41
PhyloP100
0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2502815; hg19: chr1-161203227; COSMIC: COSV63469785; COSMIC: COSV63469785; API